Fabian Schmidt Laboratory of Retrovirology The Rockefeller University Biography Publications Institution JoVE Articles Fabian Schmidt has not added a biography. If you are Fabian Schmidt and would like to personalize this page please email our Author Liaison for assistance. Publications Epistasis Lowers the Genetic Barrier to SARS-CoV-2 Neutralizing Antibody Escape Nature Communications. Jan, 2023 | Pubmed ID: 36653360 Antibody Feedback Regulates Immune Memory After SARS-CoV-2 MRNA Vaccination Nature. Jan, 2023 | Pubmed ID: 36473496 Memory B Cell Responses to Omicron Subvariants After SARS-CoV-2 MRNA Breakthrough Infection in Humans The Journal of Experimental Medicine. Dec, 2022 | Pubmed ID: 36149398 Epistasis Lowers the Genetic Barrier to SARS-CoV-2 Neutralizing Antibody Escape BioRxiv : the Preprint Server for Biology. Aug, 2022 | Pubmed ID: 36032981 Antibody Feedback Regulation of Memory B Cell Development in SARS-CoV-2 MRNA Vaccination MedRxiv : the Preprint Server for Health Sciences. Aug, 2022 | Pubmed ID: 35982682 Gut Microbiota-derived Metabolites Confer Protection Against SARS-CoV-2 Infection Gut Microbes. 2022 | Pubmed ID: 35915556 Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection Open Forum Infectious Diseases. Jul, 2022 | Pubmed ID: 35818364 Antibody Evolution to SARS-CoV-2 After Single-dose Ad26.COV2.S Vaccine in Humans The Journal of Experimental Medicine. Aug, 2022 | Pubmed ID: 35776090 Longitudinal Variation in SARS-CoV-2 Antibody Levels and Emergence of Viral Variants: a Serological Analysis The Lancet. Microbe. Jul, 2022 | Pubmed ID: 35636436 Analysis of Memory B Cells Identifies Conserved Neutralizing Epitopes on the N-terminal Domain of Variant SARS-Cov-2 Spike Proteins Immunity. Jun, 2022 | Pubmed ID: 35447092 Increased Memory B Cell Potency and Breadth After a SARS-CoV-2 MRNA Boost Nature. Jul, 2022 | Pubmed ID: 35447027 Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins BioRxiv : the Preprint Server for Biology. Feb, 2022 | Pubmed ID: 35132412 Plasma Neutralization Properties of the SARS-CoV-2 Omicron Variant MedRxiv : the Preprint Server for Health Sciences. Dec, 2021 | Pubmed ID: 34931199 Highly Synergistic Combinations of Nanobodies That Target SARS-CoV-2 and Are Resistant to Escape ELife. Dec, 2021 | Pubmed ID: 34874007 Low-dose in Vivo Protection and Neutralization Across SARS-CoV-2 Variants by Monoclonal Antibody Combinations Nature Immunology. Dec, 2021 | Pubmed ID: 34716452 Replication and Single-cycle Delivery of SARS-CoV-2 Replicons Science (New York, N.Y.). Nov, 2021 | Pubmed ID: 34648371 Anti-SARS-CoV-2 Receptor-binding Domain Antibody Evolution After MRNA Vaccination Nature. Dec, 2021 | Pubmed ID: 34619745 High Genetic Barrier to SARS-CoV-2 Polyclonal Neutralizing Antibody Escape Nature. Dec, 2021 | Pubmed ID: 34544114 Broad Cross-reactivity Across Sarbecoviruses Exhibited by a Subset of COVID-19 Donor-derived Neutralizing Antibodies Cell Reports. Sep, 2021 | Pubmed ID: 34534459 Affinity Maturation of SARS-CoV-2 Neutralizing Antibodies Confers Potency, Breadth, and Resilience to Viral Escape Mutations Immunity. Aug, 2021 | Pubmed ID: 34331873 Longitudinal Variation in SARS-CoV-2 Antibody Levels and Emergence of Viral Variants: Implications for the Ability of Serological Assays to Predict Immunity MedRxiv : the Preprint Server for Health Sciences. Jul, 2021 | Pubmed ID: 34268524 Mapping Mutations to the SARS-CoV-2 RBD That Escape Binding by Different Classes of Antibodies Nature Communications. Jul, 2021 | Pubmed ID: 34234131 Naturally Enhanced Neutralizing Breadth Against SARS-CoV-2 One Year After Infection Nature. Jul, 2021 | Pubmed ID: 34126625 Nanobodies from Camelid Mice and Llamas Neutralize SARS-CoV-2 Variants Nature. Jul, 2021 | Pubmed ID: 34098567 Broad Cross-reactivity Across Sarbecoviruses Exhibited by a Subset of COVID-19 Donor-derived Neutralizing Antibodies BioRxiv : the Preprint Server for Biology. Apr, 2021 | Pubmed ID: 33948592 Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2 BioRxiv : the Preprint Server for Biology. Apr, 2021 | Pubmed ID: 33851164 Development of Potency, Breadth and Resilience to Viral Escape Mutations in SARS-CoV-2 Neutralizing Antibodies BioRxiv : the Preprint Server for Biology. Mar, 2021 | Pubmed ID: 33758864 Mutational Escape from the Polyclonal Antibody Response to SARS-CoV-2 Infection is Largely Shaped by a Single Class of Antibodies BioRxiv : the Preprint Server for Biology. Mar, 2021 | Pubmed ID: 33758856 MRNA Vaccine-elicited Antibodies to SARS-CoV-2 and Circulating Variants Nature. Apr, 2021 | Pubmed ID: 33567448 Evolution of Antibody Immunity to SARS-CoV-2 Nature. Mar, 2021 | Pubmed ID: 33461210 Antibody Potency, Effector Function, and Combinations in Protection and Therapy for SARS-CoV-2 Infection in Vivo The Journal of Experimental Medicine. Mar, 2021 | Pubmed ID: 33211088 Escape from Neutralizing Antibodies by SARS-CoV-2 Spike Protein Variants ELife. Oct, 2020 | Pubmed ID: 33112236 Antibody Potency, Effector Function and Combinations in Protection from SARS-CoV-2 Infection BioRxiv : the Preprint Server for Biology. Sep, 2020 | Pubmed ID: 32995782 Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients Journal of Clinical Microbiology. Nov, 2020 | Pubmed ID: 32917729 Measuring SARS-CoV-2 Neutralizing Antibody Activity Using Pseudotyped and Chimeric Viruses The Journal of Experimental Medicine. Nov, 2020 | Pubmed ID: 32692348 Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies Cell. Aug, 2020 | Pubmed ID: 32645326 Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients MedRxiv : the Preprint Server for Health Sciences. Sep, 2020 | Pubmed ID: 32577675 Measuring SARS-CoV-2 Neutralizing Antibody Activity Using Pseudotyped and Chimeric Viruses BioRxiv : the Preprint Server for Biology. Jun, 2020 | Pubmed ID: 32577658 Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies BioRxiv : the Preprint Server for Biology. May, 2020 | Pubmed ID: 32577645 Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals Nature. Aug, 2020 | Pubmed ID: 32555388 Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals BioRxiv : the Preprint Server for Biology. May, 2020 | Pubmed ID: 32511384 Rhabdo-immunodeficiency Virus, a Murine Model of Acute HIV-1 Infection ELife. Oct, 2019 | Pubmed ID: 31644426 Vesicular Stomatitis Virus Transcription Is Inhibited by TRIM69 in the Interferon-Induced Antiviral State Journal of Virology. Dec, 2019 | Pubmed ID: 31578292 Derivation of Simian Tropic HIV-1 Infectious Clone Reveals Virus Adaptation to a New Host Proceedings of the National Academy of Sciences of the United States of America. May, 2019 | Pubmed ID: 31048506 HIV-1-induced AIDS in Monkeys Science (New York, N.Y.). Jun, 2014 | Pubmed ID: 24948736 Gene Editing of Primary Rhesus Macaque B Cells Harald Hartweger1, Rajeev Gautam2, Yoshiaki Nishimura2, Fabian Schmidt3,5, Kai-Hui Yao1, Amelia Escolano1,6, Mila Jankovic1, Malcolm A. Martin2, Michel C. Nussenzweig1,4 1Laboratory of Molecular Immunology, The Rockefeller University, 2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 3Laboratory of Retrovirology, The Rockefeller University, 4Howard Hughes Medical Institute, The Rockefeller University, 5Laboratory of Applied Virology and Precision Medicine, King Abdullah University of Science and Technology (KAUST), 6Vaccine and Immunotherapy Center, Wistar Institute JoVE 64858 Inmunología e infección
Gene Editing of Primary Rhesus Macaque B Cells Harald Hartweger1, Rajeev Gautam2, Yoshiaki Nishimura2, Fabian Schmidt3,5, Kai-Hui Yao1, Amelia Escolano1,6, Mila Jankovic1, Malcolm A. Martin2, Michel C. Nussenzweig1,4 1Laboratory of Molecular Immunology, The Rockefeller University, 2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 3Laboratory of Retrovirology, The Rockefeller University, 4Howard Hughes Medical Institute, The Rockefeller University, 5Laboratory of Applied Virology and Precision Medicine, King Abdullah University of Science and Technology (KAUST), 6Vaccine and Immunotherapy Center, Wistar Institute JoVE 64858 Inmunología e infección